Quebec, Canada

Dirk Bergmaier

This inventor holds 1 USPTO granted patent. Top assignee: Universitè Laval. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dirk Bergmaier. Retrieved from https://idiyas.com/inventor/dirk-bergmaier-ggoe7z1l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dirk Bergmaier: Innovator in Probiotic Technology

Introduction

Dirk Bergmaier is a notable inventor based in Québec, Canada. He has made significant contributions to the field of probiotic technology, focusing on methods to enhance the characteristics of microbial cells. His work aims to improve the health benefits of probiotics, particularly in the gastrointestinal tract of animals.

Latest Patents

Dirk Bergmaier holds 1 patent for a method and system for the modulation of microbial cell characteristics. This innovative patent describes a technique for altering various characteristics of probiotic cells, which includes increasing their resistance to stresses, drugs, and chemical agents. The system is designed to produce probiotics with enhanced features that can provide health benefits.

Career Highlights

Bergmaier is affiliated with Université Laval, where he conducts research and development in the field of probiotics. His work has been instrumental in advancing the understanding of microbial cell modulation and its applications in health.

Collaborations

Dirk collaborates with esteemed colleagues such as Christophe Lacroix and Ismail Fliss. Their combined expertise contributes to the innovative research being conducted at Université Laval.

Conclusion

Dirk Bergmaier is a pioneering inventor whose work in probiotic technology is paving the way for advancements in health benefits through microbial cell modulation. His contributions are significant in the field and continue to influence research and development in probiotics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…